New phase III RACE trial demonstrates that adding Eltrombopag to standard immunosuppressive treatment is safe and increases response rates in…
Read More
https://www.profitableratecpm.com/k8bug8jptn?key=965b36f411de7fc34d9fa4e3ea16d79b
Skip to contentNew phase III RACE trial demonstrates that adding Eltrombopag to standard immunosuppressive treatment is safe and increases response rates in…
Read MoreIndia sees 20,000 aplastic anemia cases yearly, with many succumbing due to inadequate resources for vital treatments like transplants or…
Read More